Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.

Following peripheral nerve injury microglia accumulate within the spinal cord and adopt a proinflammatory phenotype a process which contributes to the development of neuropathic pain. We have recently shown that neuregulin-1, a growth factor released following nerve injury, activates erbB 2, 3, and...

詳細記述

書誌詳細
主要な著者: Calvo, M, Zhu, N, Grist, J, Ma, Z, Loeb, J, Bennett, D
フォーマット: Journal article
言語:English
出版事項: 2011
_version_ 1826261377087438848
author Calvo, M
Zhu, N
Grist, J
Ma, Z
Loeb, J
Bennett, D
author_facet Calvo, M
Zhu, N
Grist, J
Ma, Z
Loeb, J
Bennett, D
author_sort Calvo, M
collection OXFORD
description Following peripheral nerve injury microglia accumulate within the spinal cord and adopt a proinflammatory phenotype a process which contributes to the development of neuropathic pain. We have recently shown that neuregulin-1, a growth factor released following nerve injury, activates erbB 2, 3, and 4 receptors on microglia and stimulates proliferation, survival and chemotaxis of these cells. Here we studied the intracellular signaling pathways downstream of neuregulin-1-erbB activation in microglial cells. We found that neuregulin-1 in vitro induced phosphorylation of ERK1/2 and Akt without activating p38MAPK. Using specific kinase inhibitors we found that the mitogenic effect of neuregulin-1 on microglia was dependant on MEK/ERK1/2 pathway, the chemotactic effect was dependant on PI3K/Akt signaling and survival was dependant on both pathways. Intrathecal treatment with neuregulin-1 was associated with microgliosis and development of mechanical and cold pain related hypersensitivity which was dependant on ERK1/2 phosphorylation in microglia. Spinal nerve ligation results in a robust microgliosis and sustained ERK1/2 phosphorylation within these cells. This pathway is downstream of neuregulin-1/erbB signaling since its blockade resulted in a significant reduction in microglial ERK1/2 phosphorylation. Inhibition of the MEK/ERK1/2 pathway resulted in decreased spinal microgliosis and in reduced mechanical and cold hypersensitivity after peripheral nerve damage. We conclude that neuregulin-1 released after nerve injury activates microglial erbB receptors which consequently stimulates the MEK/ERK1/2 pathway that drives microglial proliferation and contributes to the development of neuropathic pain.
first_indexed 2024-03-06T19:20:26Z
format Journal article
id oxford-uuid:19e6fbe0-3b35-427b-a1e3-3d349155c7a3
institution University of Oxford
language English
last_indexed 2024-03-06T19:20:26Z
publishDate 2011
record_format dspace
spelling oxford-uuid:19e6fbe0-3b35-427b-a1e3-3d349155c7a32022-03-26T10:51:38ZFollowing nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:19e6fbe0-3b35-427b-a1e3-3d349155c7a3EnglishSymplectic Elements at Oxford2011Calvo, MZhu, NGrist, JMa, ZLoeb, JBennett, DFollowing peripheral nerve injury microglia accumulate within the spinal cord and adopt a proinflammatory phenotype a process which contributes to the development of neuropathic pain. We have recently shown that neuregulin-1, a growth factor released following nerve injury, activates erbB 2, 3, and 4 receptors on microglia and stimulates proliferation, survival and chemotaxis of these cells. Here we studied the intracellular signaling pathways downstream of neuregulin-1-erbB activation in microglial cells. We found that neuregulin-1 in vitro induced phosphorylation of ERK1/2 and Akt without activating p38MAPK. Using specific kinase inhibitors we found that the mitogenic effect of neuregulin-1 on microglia was dependant on MEK/ERK1/2 pathway, the chemotactic effect was dependant on PI3K/Akt signaling and survival was dependant on both pathways. Intrathecal treatment with neuregulin-1 was associated with microgliosis and development of mechanical and cold pain related hypersensitivity which was dependant on ERK1/2 phosphorylation in microglia. Spinal nerve ligation results in a robust microgliosis and sustained ERK1/2 phosphorylation within these cells. This pathway is downstream of neuregulin-1/erbB signaling since its blockade resulted in a significant reduction in microglial ERK1/2 phosphorylation. Inhibition of the MEK/ERK1/2 pathway resulted in decreased spinal microgliosis and in reduced mechanical and cold hypersensitivity after peripheral nerve damage. We conclude that neuregulin-1 released after nerve injury activates microglial erbB receptors which consequently stimulates the MEK/ERK1/2 pathway that drives microglial proliferation and contributes to the development of neuropathic pain.
spellingShingle Calvo, M
Zhu, N
Grist, J
Ma, Z
Loeb, J
Bennett, D
Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.
title Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.
title_full Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.
title_fullStr Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.
title_full_unstemmed Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.
title_short Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.
title_sort following nerve injury neuregulin 1 drives microglial proliferation and neuropathic pain via the mek erk pathway
work_keys_str_mv AT calvom followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway
AT zhun followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway
AT gristj followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway
AT maz followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway
AT loebj followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway
AT bennettd followingnerveinjuryneuregulin1drivesmicroglialproliferationandneuropathicpainviathemekerkpathway